Inventor · disambiguated record
Hermona Soreq
Also filed as: EVRON TAMA · SOREQ HERMONA
24 granted patents·24 pending applications·470 citations·filing 1990–2021
96Inventor score
Files withYISSUM RES DEV CO29SOREQ HERMONA6YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD4BEKENSTEIN URIAH2MOR RESEARCH APPLIC LTD1
Top patents by PatentIndex Score
48 records- 0195US7456154B2Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereofYISSUM RES DEV CO·Filed 2006·Granted Nov 25, 2008·121 cites·9 claims
- 0290US6770799B2Expression of recombinant human acetylcholinesterase in transgenic plantsTHOMPSON BOYCE PLANT RES·Filed 2001·Granted Aug 3, 2004·23 cites·11 claims
- 0389US5891725ASynthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing themYISSUM RES DEV CO·Filed 1993·Granted Apr 6, 1999·141 cites·11 claims
- 0482US7074915B2Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereofYISSUM RES DEV CO·Filed 2003·Granted Jul 11, 2006·19 cites·14 claims
- 0574US5932780ATransgenic non-human animal assay system for anti-cholinesterase substancesYISSUM RES DEV CO·Filed 1995·Granted Aug 3, 1999·33 cites·9 claims
- 0672US7494783B2Method for assessing trait anxiety by determining cholinergic statusYISSUM RES DEV CO·Filed 2006·Granted Feb 24, 2009·2 cites·16 claims
- 0769US8722876B2Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disordersYISSUM RES DEV CO·Filed 2013·Granted May 13, 2014·1 cites·10 claims
- 0868US7063948B1Uses of antibodies against AChE and peptides thereofYISSUM RES DEV CO·Filed 2000·Granted Jun 20, 2006·1 cites·3 claims
- 0965US7067486B2Acetylcholinesterase-derived peptides and uses thereofYISSUM RES DEV CO·Filed 2001·Granted Jun 27, 2006·2 cites·15 claims
- 1064US11193034B2Hybrid nanoparticles as photoinitiatorsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Granted Dec 7, 2021·0 cites·14 claims
- 1164US2011136897A1Toll-like receptor 9 agonists for the treatment of anxiety-related disorders and inflammatory disordersYISSUM RES DEV CO·Filed 2009·Application pending·0 cites
- 1263US6025183ATransgenic animal assay system for anti-cholinesterase substancesYISSUM RES DEV CO·Filed 1997·Granted Feb 15, 2000·22 cites·7 claims
- 1361US10174320B2Downregulating miR-132 for the treatment of lipid related disordersYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2015·Granted Jan 8, 2019·1 cites·19 claims
- 1461US5215909AHuman cholinesterase genesYEDA RES & DEV·Filed 1990·Granted Jun 1, 1993·19 cites·7 claims
- 1561US2010216868A1Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficialYISSUM RES DEV CO·Filed 2008·Application pending·0 cites
- 1658US5595903AGenetically engineered human acetylcholinesteraseYISSUM RES DEV CO·Filed 1993·Granted Jan 21, 1997·17 cites·19 claims
- 1758US2004148657A1Expression of recombinant human acetylcholinesterase in transgenic plantsFiled 2004·Application pending·0 cites
- 1857US10442944B2Hybrid nanoparticles as photoinitiatorsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2016·Granted Oct 15, 2019·0 cites·18 claims
- 1957US6110742ASynthetic antisense oligodeoxynucleotides targeted to AChEYISSUM RES DEV CO·Filed 1997·Granted Aug 29, 2000·12 cites·8 claims
- 2057US2009281165A1Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereofYISSUM RES DEV CO·Filed 2008·Application pending·0 cites
- 2157US2007293452A1Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficialYISSUM RES DEV CO·Filed 2007·Application pending·0 cites
- 2256US2008306014A1Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficialYISSUM RES DEV CO·Filed 2007·Application pending·0 cites
- 2356US2007065882A1Acetylcholinesterase-derived peptides and uses thereofSOREQ HERMONA·Filed 2006·Application pending·0 cites
- 2456US2013317092A1Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficialYISSUM RES DEV CO·Filed 2013·Application pending·0 cites
- 2555US2022098588A1METHODS FOR CONTROLLING SEIZURES BY MANIPULATING THE LEVELS OF MICRORNA-211 (miR-211) IN THE BRAINBEKENSTEIN URIAH·Filed 2021·Application pending·0 cites
- 2655US2009005331A1AChE antisense oligonucleotide as an anti-inflammatory agentMOR RESEARCH APPLIC LTD·Filed 2007·Application pending·0 cites
- 2754US11225661B2Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brainBEKENSTEIN URIAH·Filed 2019·Granted Jan 18, 2022·0 cites·15 claims
- 2853US5807671AMethod of screening for genetic predisposition to anticholinesterase therapyYISSUM RES DEV CO·Filed 1995·Granted Sep 15, 1998·15 cites·2 claims
- 2953US2012295963A1Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficialSOREQ HERMONA·Filed 2012·Application pending·0 cites
- 3053US2006166204A1Parkinson's disease susceptibility haptotype as a tool for genetic screeningUNIV BEN GURION·Filed 2003·Application pending·0 cites
- 3150US6987211B1Transgenic non-human mammals producing a cholinesterase in their milkYISSUM RES DEV CO·Filed 1999·Granted Jan 17, 2006·12 cites·8 claims
- 3250US6326139B1Method of screening for genetic predisposition to anticholinesterase therapyYISSUM RES DEV COMPANY OF HEBR·Filed 1996·Granted Dec 4, 2001·12 cites·11 claims
- 3350US2009169520A1Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril FormationYISSUM RES DEV CO·Filed 2005·Application pending·0 cites
- 3450US2006069051A1AChE antisense oligonucleotide as an anti-inflammatory agentSOREQ HERMONA·Filed 2005·Application pending·0 cites
- 3548US2010279381A1Acetylcholinesterase (AChE) variants of the N-terminusYISSUM RES DEV CO·Filed 2006·Application pending·0 cites
- 3646US7838493B2Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereofYISSUM RES DEV CO·Filed 2005·Granted Nov 23, 2010·0 cites·6 claims
- 3746US2011064716A1Materials and methods for treating or preventing organophosphate exposure associated damageYISSUM RES DEV CO·Filed 2007·Application pending·0 cites
- 3845US2004016008A1Hybrid transgenic mouse with accelerated onsent of Alzheimer type amyloid plaques in brainFiled 2003·Application pending·0 cites
- 3944US6475998B1Methods and compositions for the treatment of injury to the central nervous systemYISSUM RES DEV CO·Filed 1998·Granted Nov 5, 2002·5 cites·20 claims
- 4043US2015119447A1Clustered single nucleotide polymorphisms in the human acetylcholinesterase gene and uses thereof in diagnosis and therapyYISSUM RES DEV CO·Filed 2013·Application pending·0 cites
- 4142US2019078090A1Downregulating mir-132 for the treatment of lipid related disordersYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Application pending·0 cites
- 4240US6121046ASynthetic antisense oligodeoxynucleotides targeted to human acheYISSUM RES DEV CO·Filed 1997·Granted Sep 19, 2000·4 cites·14 claims
- 4340US2013210901A1Method of treating neurodegenerative diseasesSOREQ HERMONA·Filed 2011·Application pending·0 cites
- 4440US2006121536A1Novel uses of antibodies against AChE and peptides thereofSOREQ HERMONA·Filed 2006·Application pending·0 cites
- 4539US6258780B1Method and composition for enabling passage through the blood-brain-barrierYISSUM RES DEV CO·Filed 1997·Granted Jul 10, 2001·8 cites·10 claims
- 4637US2013018081A1AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENTYISSUM RES DEV CO·Filed 2012·Application pending·0 cites
- 4737US2013164288A1Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's diseaseSOREQ HERMONA·Filed 2011·Application pending·0 cites
- 4836US2011039791A1Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereofYISSUM RES DEV CO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hermona Soreq files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →